H1B Report
Side-by-side comparison

WIPRO LIMITED vs XenoBiotic Laboratories, Inc., a div. of WuXi

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
WIPRO LIMITED
NJRank #6FEIN 98-0154401
Entity B
XenoBiotic Laboratories, Inc., a div. of WuXi
NJRank #FEIN 47-1896603

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricWIPRO LIMITEDXenoBiotic Laboratories, Inc., a div. of WuXi
Total filings72,39251
Certified %91.61%96.08%
Denied %0.37%1.96%
Withdrawn %1.37%1.96%
Cert-withdrawn %6.64%0.00%
Rank#6
Active yearsFY2010–FY2026FY2015–FY2026
Worksite stateNJNJ

Outcomes — WIPRO LIMITED

DOL case-status mix.

Outcome breakdown: Certified 91.6%, Cert-withdrawn 6.6%, Withdrawn 1.4%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%

Outcomes — XenoBiotic Laboratories, Inc., a div. of WuXi

DOL case-status mix.

Outcome breakdown: Certified 96.1%, Withdrawn 2.0%, Denied 2.0%
Outcome breakdown
OutcomeShare
Certified96.1%
Withdrawn2.0%
Denied2.0%
Certified96.1%
Withdrawn2.0%
Denied2.0%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

WIPRO LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103,039
FY20113,025
FY20127,031
FY20136,574
FY20148,104
FY201511,824
FY201610,254
FY20175,012
FY20186,067
FY20194,154
FY202094
FY2021128
FY202297
FY2023554
FY20242,296
FY20252,289
FY20261,850
XenoBiotic Laboratories, Inc., a div. of WuXi
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20110
FY20120
FY20130
FY20140
FY201511
FY201610
FY20177
FY201811
FY20193
FY20200
FY20210
FY20220
FY20230
FY20243
FY20254
FY20262

Top 5 occupations — WIPRO LIMITED

Top 5 occupations — XenoBiotic Laboratories, Inc., a div. of WuXi

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.